Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
Michael A Steinman, Cynthia M Boyd, Kenneth E Schmader
No abstract text is available yet for this article.
July 22, 2021: JAMA
#2
Timothy A Bates, Hans C Leier, Zoe L Lyski, James R Goodman, Marcel E Curlin, William B Messer, Fikadu G Tafesse
No abstract text is available yet for this article.
July 21, 2021: JAMA
#3
Rita Rubin
No abstract text is available yet for this article.
July 21, 2021: JAMA
#4
Kevin A Schulman, Michael D Greicius, Barak Richman
No abstract text is available yet for this article.
July 19, 2021: JAMA
#5
Paul Simon, Alex Ho, Megha D Shah, Rashmi Shetgiri
No abstract text is available yet for this article.
July 19, 2021: JAMA
#6
Catherine E Oldenburg, Benjamin A Pinsky, Jessica Brogdon, Cindi Chen, Kevin Ruder, Lina Zhong, Fanice Nyatigo, Catherine A Cook, Armin Hinterwirth, Elodie Lebas, Travis Redd, Travis C Porco, Thomas M Lietman, Benjamin F Arnold, Thuy Doan
Importance: Azithromycin has been hypothesized to have activity against SARS-CoV-2. Objective: To determine whether oral azithromycin in outpatients with SARS-CoV-2 infection leads to absence of self-reported COVID-19 symptoms at day 14. Design, Setting, and Participants: Randomized clinical trial of azithromycin vs matching placebo conducted from May 2020 through March 2021. Outpatients from the US were enrolled remotely via internet-based surveys and followed up for 21 days...
July 16, 2021: JAMA
#7
Thomas Radtke, Agne Ulyte, Milo A Puhan, Susi Kriemler
No abstract text is available yet for this article.
July 15, 2021: JAMA
#8
David R Holtgrave, Sten H Vermund, Leana S Wen
No abstract text is available yet for this article.
July 15, 2021: JAMA
#9
Jennifer Abbasi
No abstract text is available yet for this article.
July 14, 2021: JAMA
#10
Inbal Goldshtein, Daniel Nevo, David M Steinberg, Ran S Rotem, Malka Gorfine, Gabriel Chodick, Yaakov Segal
Importance: Data on BNT162b2 messenger RNA (mRNA) vaccine (Pfizer-BioNTech) effectiveness and safety in pregnancy are currently lacking because pregnant women were excluded from the phase 3 trial. Objective: To assess the association between receipt of BNT162b2 mRNA vaccine and risk of SARS-CoV-2 infection among pregnant women. Design, Setting, and Participants: This was a retrospective cohort study within the pregnancy registry of a large state-mandated health care organization in Israel...
July 12, 2021: JAMA
#11
Meredith B Rosenthal
No abstract text is available yet for this article.
July 9, 2021: JAMA
#12
Hannah Miksenas, James L Januzzi, Pradeep Natarajan
No abstract text is available yet for this article.
July 8, 2021: JAMA
#13
Aaron Kofman, Rami Kantor, Eli Y Adashi
No abstract text is available yet for this article.
July 8, 2021: JAMA
#14
Sudhakar V Nuti, Katrina Armstrong
No abstract text is available yet for this article.
July 7, 2021: JAMA
#15
Bridget M Kuehn
No abstract text is available yet for this article.
July 7, 2021: JAMA
#16
Michael A Matthay, Anne F Luetkemeyer
No abstract text is available yet for this article.
July 6, 2021: JAMA
#17
Manu Shankar-Hari, Claire L Vale, Peter J Godolphin, David Fisher, Julian P T Higgins, Francesca Spiga, Jelena Savovic, Jayne Tierney, Gabriel Baron, Julie S Benbenishty, Lindsay R Berry, Niklas Broman, Alexandre Biasi Cavalcanti, Roos Colman, Stefanie L De Buyser, Lennie P G Derde, Pere Domingo, Sharifah Faridah Omar, Ana Fernandez-Cruz, Thijs Feuth, Felipe Garcia, Rosario Garcia-Vicuna, Isidoro Gonzalez-Alvaro, Anthony C Gordon, Richard Haynes, Olivier Hermine, Peter W Horby, Nora K Horick, Kuldeep Kumar, Bart N Lambrecht, Martin J Landray, Lorna Leal, David J Lederer, Elizabeth Lorenzi, Xavier Mariette, Nicolas Merchante, Nor Arisah Misnan, Shalini V Mohan, Michael C Nivens, Jarmo Oksi, Jose A Perez-Molina, Reuven Pizov, Raphael Porcher, Simone Postma, Reena Rajasuriar, Athimalaipet V Ramanan, Philippe Ravaud, Pankti D Reid, Abraham Rutgers, Aranzazu Sancho-Lopez, Todd B Seto, Sumathi Sivapalasingam, Arvinder Singh Soin, Natalie Staplin, John H Stone, Garth W Strohbehn, Jonas Sunden-Cullberg, Julian Torre-Cisneros, Larry W Tsai, Hubert van Hoogstraten, Tom van Meerten, Viviane Cordeiro Veiga, Peter E Westerweel, Srinivas Murthy, Janet V Diaz, John C Marshall, Jonathan A C Sterne
Importance: Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized for COVID-19 have variously reported benefit, no effect, and harm. Objective: To estimate the association between administration of IL-6 antagonists compared with usual care or placebo and 28-day all-cause mortality and other outcomes. Data Sources: Trials were identified through systematic searches of electronic databases between October 2020 and January 2021...
July 6, 2021: JAMA
#18
Allan J Walkey, Anica Law, Nicholas A Bosch
No abstract text is available yet for this article.
July 2, 2021: JAMA
#19
Mayte Sánchez van Kammen, Mirjam R Heldner, Justine Brodard, Adrian Scutelnic, Suzanne Silvis, Verena Schroeder, Johanna A Kremer Hovinga, Saskia Middeldorp, Marcel Levi, Sini Hiltunen, Erik Lindgren, Maryam Mansour, Antonio Arauz, Miguel A Barboza, Susanna M Zuurbier, Diana Aguiar de Sousa, Jose M Ferro, Urs Fischer, Thalia S Field, Katarina Jood, Turgut Tatlisumak, Jukka Putaala, Marcel Arnold, Jonathan M Coutinho
Importance: Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. Objective: To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of platelet factor 4/heparin antibodies in patients diagnosed with cerebral venous sinus thrombosis prior to the COVID-19 pandemic...
July 2, 2021: JAMA
#20
Matthew M Kavanagh, Lawrence O Gostin, Madhavi Sunder
No abstract text is available yet for this article.
July 1, 2021: JAMA
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
